| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2862575 | American Journal of Hypertension | 2007 | 9 Pages |
Abstract
Both captopril and allylmercaptocaptopril are effective in attenuating multiple abnormalities of metabolic syndrome. Allylmercaptocaptopril may have additional effectiveness on improving glucose tolerance, further lowering blood pressure, reducing cardiac hypertrophy, preventing weight gain, and protecting against renal disease.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Paul Ernsberger, Janean L. Johnson, Talma Rosenthal, David Mirelman, Richard J. Koletsky,